Literature DB >> 1103615

Aspergillus antibody in patients with cystic fibrosis.

E J Bardana, K L Sobti, F D Cianciulli, M J Noonan.   

Abstract

The respiratory flora of patients with cystic fibrosis (CF) frequently includes Aspergillus, and 30% of their serum samples have been observed to contain precipitating antibody to this fungus. Serum from 61 CF patients, 60 healthy persons, and three patients with CF and allergic bronchopulmonary aspergillosis was studied, using a quantitative assay for antibody to A fumigatus. Although CF patients had significantly higher levels of Aspergillus antibody, some antibody was found in all serum samples from normal individuals. Binding was immunologically specific for A fumigatus. Serum IgE levels and dermal reactivity to Aspergillus were similar in both CF and normal subjects. Increased levels of Aspergillus antibody in CF patients probably reflect pulmonary colonization, which only rarely causes infection or sensitization.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1103615     DOI: 10.1001/archpedi.1975.02120470020005

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  9 in total

1.  Evaluation of the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis.

Authors:  A Oliva; P Flori; C Hennequin; J-C Dubus; M Reynaud-Gaubert; D Charpin; J M Vergnon; P Gay; A Colly; R Piarroux; H Pelloux; S Ranque
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  Atopy and bronchial reactivity in older patients with cystic fibrosis.

Authors:  M J Tobin; O Maguire; D Reen; E Tempany; M X Fitzgerald
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

3.  Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.

Authors:  A Bauernfeind; R M Bertele; K Harms; G Hörl; R Jungwirth; C Petermüller; B Przyklenk; C Weisslein-Pfister
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

4.  Serologic response to Candida albicans and Aspergillus fumigatus in cystic fibrosis.

Authors:  B Przyklenk; A Bauernfeind; G Hörl; G Emminger
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

5.  Allergic bronchopulmonary aspergillosis (ABPA): studies on the general and specific humoral response.

Authors:  R S Sandhu; E J Bardana; Z U Khan; D M Dordevich
Journal:  Mycopathologia       Date:  1978-04-14       Impact factor: 2.574

Review 6.  The relationship between atopy and cystic fibrosis.

Authors:  R W Wilmott
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

7.  Pseudomonas infection, allergy, and cystic fibrosis.

Authors:  R W Pitcher-Wilmott; R J Levinsky; I Gordon; M W Turner; D J Matthew
Journal:  Arch Dis Child       Date:  1982-08       Impact factor: 3.791

8.  Serum antibodies to Aspergillus fumigatus catalase in patients with cystic fibrosis.

Authors:  H Schønheyder; T Jensen; I H Laessøe; N Høiby; C Koch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

Review 9.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.